Novartis Board of Directors announced on Monday the appointment of Gilbert Ghostine as Chairman-designate of the new Board of Directors of Sandoz.
Ghostine has served as CEO of Geneva-based Firmenich, the world’s largest privately owned perfume and taste company, since 2014.
Gilbert Ghostine will become Chairman of the New Board of Directors of Sandoz, which will be formed following the spin-off from Novartis in the second half of 2023, subject to final Novartis Board of Directors and shareholder approvals.
Ghostine is an experienced business leader with a track record of growing and transforming businesses in competitive industries.
He held executive and senior leadership positions at Firmenich and Diageo in a career spanning three decades.
He currently serves on two boards of directors; at Danone, where he is a member of the audit committee, and at Four Seasons Hotels & Resorts, where he chairs the remuneration and nomination committee.
He holds a master’s degree in Business Administration from Saint Joseph University, Lebanon and completed Harvard Business School’s Advanced Management Programme.
